Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications.
Int J Mol Sci. 2022 Dec 27;24(1):446. doi: 10.3390/ijms24010446.
Int J Mol Sci. 2022.
PMID: 36613900
Free PMC article.
Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels.
Ráduly AP, Tóth A, Sárkány F, Horváth B, Szentandrássy N, Nánási PP, Csanádi Z, Édes I, Papp Z, Borbély A.
Ráduly AP, et al. Among authors: sarkany f.
ESC Heart Fail. 2023 Apr;10(2):1326-1335. doi: 10.1002/ehf2.14300. Epub 2023 Feb 1.
ESC Heart Fail. 2023.
PMID: 36722665
Free PMC article.
Item in Clipboard
Drug Candidate BGP-15 Prevents Isoproterenol-Induced Arrhythmias and Alters Heart Rate Variability (HRV) in Telemetry-Implanted Rats.
Bernat B, Erdelyi R, Fazekas L, Garami G, Szekeres RM, Takacs B, Bombicz M, Varga B, Sarkany F, Raduly AP, Romanescu DD, Papp Z, Toth A, Szilvassy Z, Juhasz B, Priksz D.
Bernat B, et al. Among authors: sarkany f.
Pharmaceuticals (Basel). 2023 Feb 26;16(3):359. doi: 10.3390/ph16030359.
Pharmaceuticals (Basel). 2023.
PMID: 36986459
Free PMC article.
Item in Clipboard
Cite
Cite